The distributor reported on behalf of the customer that the a1059 mayfield modified skull clamp lock swivel adapter was broken.Additional information received on 12sep2019 indicating that the device was in contact with the patient however, no patient injury, no delay and no revision or medical intervention required.
|
Additional information received that the incident occurred on (b)(6) 2019.The device was returned for evaluation and the thread on the base unit for swivel adaptor torque screw has been cross threaded.This is consistent with user error / improper use.General maintenance , helicoil repair of threads, test and adjustment to return device to manufacturers specifications was required.Device history record review showed no abnormalities related to the reported failure.The device period passed all required inspection points with no associated mrr¿s, variances or rework.The reported complaint was confirmed.The definite root cause could not be reliably determined.Device identifier (b)(4).Between 05nov2019 and 30jun2020, approximately 2,200 mdrs submitted electronically by integra lifesciences via trackwise, integra's complaint handling system, were not received by cdrh due to a computer system issue.Within this time period, an error with integra's middleware, which facilitates communications between trackwise and the fda system, caused the complaint records to close and indicate we had received an acknowledgement 3 from the fda when we had not.Integra interpreted the acknowledgement as a successful submission; however, subsequent investigation revealed the acknowledgement 3 received was from our middleware and not from the fda (these acknowledgements have been retained as part of the documentation of the mdr).The malfunction was related to the relocation of the trackwise application to a new data center during the transition of integra's corporate headquarters from plainsboro, nj to princeton, nj.Previously, integra had been successfully receiving acknowledgements 1, 2, and 3 from the fda, and our records reflect these acknowledgements, including the date and time stamps.Capa pr 229048 and nc 20-011 have been opened by integra to further investigate the nonconformance and develop a corrective action plan.The middleware error has been corrected, and integra has filed mdrs since the correction and verified that the appropriate acknowledgements have been received from the fda.Integra is resubmitting all impacted mdr reports for the time period 05nov2019 through 30jun2020.Integra lifesciences contacted (b)(4), director of regulatory programs, office of product evaluation and quality and (b)(4), assistant director, mdr team, office of product evaluation and quality on july 8-9, 2020 to report these issues regarding mdr reports.
|